Home Search
cannabinoids - search results
If you're not happy with the results, please do another search
The UK CBD Market: Cannabinoids, Consumers and Confusion
Savage Cabbage Ltd give insight into the UK CBD market, defining the differences in cannabinoid products and their roles in the industry.
Cannabinoids as an alternative to opioids for chronic pain
Cannabinoids with high THC-to-CBD ratios can help to improve moderate, short-term chronic pain band may be an alternative to opioids.
The expanding scope of cannabinoids in epilepsy
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Medical Center, details the expanding scope of cannabinoids in epilepsy.
CBG: The mother of all Cannabinoids with broad antibacterial activity
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains CBG (cannabigerol), a “new” cannabinoid with vast potential in cannabis research.
How cannabinoids can be used as pain medicine
Dr Daniela Tonucci, a consultant for over 10 years, talks us through the use of cannabinoids as pain medicine.
Cannabinoids in medicine part 5: Treating COVID-19
In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.
Cannabinoids in medicine part 4: Epilepsy
In the fourth of a series of five articles, Oxford Cannabinoid Technologies discuss their expertise on cannabinoids in medicine.
Healing with cannabinoids: MS and Prostate Cancer
Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.
Medical use of cannabinoids and marijuana
In this article, Dr Gerry Morrow shares his thoughts on the medical use of cannabinoids and marijuana.
Cannabinoids in Medicine Part 3: Psoriasis and Rheumatoid Arthritis
Following the first two articles that discussed the treatment of cancer and pain, this third piece will focus on the use of cannabinoids to treat psoriasis and rheumatoid arthritis.
Cannabinoids in medicine Part 2: Pain
In the second of a series of five articles, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine.
Cannabinoids and health – from supplements to medicines
GreenLight Medicines is a supplier of quality supplements and is an active MedCan research company GreenLight, Supplements and Medicines.
Cannabinoids in medicine Part 1: Cancer
In the first of a series of five articles, Oxford Cannabinoid Technologies will discuss their expertise on the medicinal use of cannabis derivatives.
Cannabinoids for therapeutic purposes – where are we?
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group shares a perspective on the present status and potential evolution when it comes to cannabinoids for therapeutic purposes.
Medical cannabis in chronic pain management
Steph Sherer, Founder and President of Americans for Safe Access (ASA), discusses the prevalence, challenges and treatments for chronic pain management.
How the brain regulates emotions, a future with better targeted mental health treatments
Do you ever find yourself in situations where you want to scream out of frustration or anger? Well, there is a reason why you manage to keep cool on those tough days.
Therapeutic potential of the endocannabinoid system to treat chronic pain in inflammatory disease
Pharma researchers Julie Blaising and Philip Smith from F. Hoffmann-La Roche Ltd. discuss the endocannabinoid system as a pathway to treat inflammatory diseases such as Inflammatory Bowel Disease (IBD) and endometriosis.
MAGL inhibition: A novel treatment option for combating inflammatory disease?
Pharma researchers Uwe Grether and Julie Blaising from F. Hoffmann-La Roche Ltd. highlight the vast therapeutic potential of MAGL inhibition for central and peripheral diseases.
Medicinal cannabis: The future of chronic pain treatment?
Alberto Sainz Cort to discuss the prevalence of chronic pain and opioid use in the United States, as well as medical cannabis as a potential treatment for pain.
Exploring the effects of medical cannabis for chronic pain
Dr Simon Erridge of Sapphire Medical Clinics discusses the therapeutic effects of medical cannabis for chronic pain, affecting 15.5 million people in England and why more evidence is needed to support greater patient access.